← Leaderboards
Yuichiro Tanaka
Veterans Affairs Med Ctr San Francisco
$717,445
Attributed
$717,445
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $350.7K · FY2011–20$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$717,445 · 2
VA$0 · 2
By mechanism
R21$366,771 · 1
R01$350,674 · 1
I01$0 · 1
IP1$0 · 1
Top collaborators
- Rajvir Dahiya4 shared
- Yun-Fai Chris Lau4 shared
Most similar at Veterans Affairs Med Ctr San Francisco
Same institution · by research overlap
- Yun-Fai Chris Lau$1,619,926
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesBaseMalignant NeoplasmsCellsGene ExpressionPredispositionRisk FactorsTissuesCancer PatientLiteratureMissionVeteransSpecimenClinically RelevantPublishingBiological MarkersCell LineTumor ProgressionHigh RiskIncidenceInsightAffectGenetic TranscriptionPlay
Grant awards (15)
Molecular biomarkers for kidney cancer prognosis using non-coding RNAs$350,674
R01 · FY2020 · CA · contact PI
Role of catechol-O-methyltransferase gene in prostate cancer$0
I01 · FY2019 · VA · contact PI
Role of catechol-O-methyltransferase gene in prostate cancer$0
I01 · FY2018 · VA · contact PI
Role of catechol-O-methyltransferase gene in prostate cancer$0
I01 · FY2017 · VA · contact PI
Racial differences in CYP1B1 polymorphisms and risks for prostate cancer$166,714
R21 · FY2016 · CA · contact PI
Role of genetic biomarkers in clinical assessment of prostate cancer$0
IP1 · FY2016 · VA
Role of catechol-O-methyltransferase gene in prostate cancer$0
I01 · FY2016 · VA · contact PI
Racial differences in CYP1B1 polymorphisms and risks for prostate cancer$200,057
R21 · FY2015 · CA · contact PI
Role of genetic biomarkers in clinical assessment of prostate cancer$0
IP1 · FY2015 · VA
Polymorphisms of estrogen-metabolizing genes in kidney cancer$0
I01 · FY2014 · VA · contact PI
Role of genetic biomarkers in clinical assessment of prostate cancer$0
IP1 · FY2014 · VA
Polymorphisms of estrogen-metabolizing genes in kidney cancer$0
I01 · FY2013 · VA · contact PI
Role of genetic biomarkers in clinical assessment of prostate cancer$0
IP1 · FY2013 · VA
Polymorphisms of estrogen-metabolizing genes in kidney cancer$0
I01 · FY2012 · VA · contact PI
Polymorphisms of estrogen-metabolizing genes in kidney cancer$0
I01 · FY2011 · VA · contact PI